Status:

COMPLETED

Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff

Lead Sponsor:

Direction Centrale du Service de Santé des Armées

Conditions:

Sars-CoV2

Eligibility:

All Genders

18-62 years

Brief Summary

Emerging in China in December 2019, Covid-19, whose pathogen is SARS-Cov-2, was declared a global pandemic in March 2020. The clinical presentation is highly variable, ranging from asymptomatic forms ...

Eligibility Criteria

Inclusion

  • Army Training Hospital staff

Exclusion

  • Individuals who have already been confirmed Covid-19 positive
  • Individuals taking preventive anti-Covid-19 therapy or considering participating in anti-Covid-19 therapy study
  • Individuals on hydroxychloroquine
  • Pregnant or breastfeeding women
  • Non-permanent staff during the study period
  • Individuals identified for a detachment outside the metropole during the study period

Key Trial Info

Start Date :

May 14 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 15 2020

Estimated Enrollment :

845 Patients enrolled

Trial Details

Trial ID

NCT04387838

Start Date

May 14 2020

End Date

August 15 2020

Last Update

March 9 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hôpital d'Instuction des Armées Sainte-Anne

Toulon, France, 83800

2

Hôpital d'Instruction des Armées Robert Picqué

Villenave-d'Ornon, France, 33882